Oxidative stress Sample Clauses

Oxidative stress. Oxidative stress is either generated through an imbalance in the generation and removal of ROS or from a systemic inability to remove ROS-induced damage in a cell (Xxxxxx et al., 2013). The main free radicals in a cell are ROS and reactive nitric species (RNS), both by-products of aerobic metabolism and mainly produced by the mitochondrial electron transfer chain and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. Increased levels of oxidative stress markers have been found in the spinal cord and motor cortex but also serum, CSF and urine of pre- and post-mortem samples of ALS patients (Shaw et al., 1995b; Xxxx et al., 1997; Xxxxxxxx et al., 1997; Xxxxx et al., 1998; Xxxxxxx et al., 2004; Xxxxxxxxx et al., 2008). Oxidative damage to proteins, lipids and DNA were found in post-mortem tissue of SALS, mutant SOD1 related FALS cases and mutant SOD1 mice (Shaw et al., 1995a; Xxxxxxxxxxx et al., 1996; Xxxxxxx et al., 2001; Xxx et al., 2004). The cause of oxidative stress in ALS is unclear but might involve mitochondria, an activation of microglial regulated superoxide production and signalling via NADPH oxidase (Xxxxxx and Xxxxxx, 2007). NADPH oxidase is upregulated in some cases of ALS and in mutant SOD1 transgenic mouse models (Xx et al., 2006; Xxxxxx et al., 2007). Although SOD1 catalyses the conversion of superoxide into hydrogen peroxide and oxygen, the pathogenesis of ALS is not thought to be related to the enzymatic activity of SOD1. This is because modulating SOD1 activity in mutant SOD1 transgenic mice does not influence disease onset or progression (Xxxxxx et al., 1998). Alterations in the redox homeostasis also regulate gene expression of transcriptional factors such as nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and hypoxia-inducible factor 1 α (HIF-1α). These transcription factors help maintain homeostasis by regulating gene expression and have a redox regulated cysteine residue in their DNA binding site which could be influenced by the presence of ROS (Xxxxxxx, 2002). A dysregulation of NF-κB and HIF-1α was found in SALS patients (Xxxxxx et al., 2011; Xxxxxxxxx et al., 2011). Thus, oxidative stress probably aggravates other pathophysiological processes that have been observed in ALS such as excitotoxicity, mitochondrial impairment, ER stress, protein aggregation and alterations in astrocytic and microglial signalling (Xxxx et al., 2003; Xxx and Xxxxx, 2004; Xxxxxxxx et al., 2005; Xxxxxxxx et al., 2009; Xxxxx ...
AutoNDA by SimpleDocs
Oxidative stress and Cancer Cancer is a multistep process that involves multiple molecular and cellular carcinogenesis mechanisms [106]. Oxidative stress has long been known as a trigger for tumor development. Cells in every organism are exposed to various oxidizing agents both endogenous and exogenous sources. It is estimated that each human cell is exposed to approximately 105 oxidative attacks a day from hydroxyl radical and other reactive oxygen species [107-109]. As illustrated in Figure 1.3, oxidative stress may cause DNA, RNA, protein, and/or lipid damage, leading to chromosomal instability, genetic mutations, and/or modulation of cell growth that result in cancer [106]. Oxidative DNA damage is a major source of DNA mutations, with over one hundred oxidative adducts having been i entified [110, 111]. It is estimated that on average there are several thousands of DNA alterations per day in each cell caused by both endogenous and exogenous oxidative s ress [112]. The most well-established and abundant oxidative DNA base lesion is 8- hydroxydeoxy guanosine (8-OH-dG) [113].
Oxidative stress and Aging The free-radical theory of aging postulates that the process of aging process is the result of cumulative damage induced by free radical production in aerobic organisms [28]. This theory is based on the fact that the random deleterious effects of free radicals produced during aerobic metabolism accumulate over time, leading damage to DNA, protein, and lipids [130]. Under normal physiological conditions, electrons are constantly leaking from the electron transport chain and interact with oxygen to produce superoxide radicals [131]. The primary site of radical oxygen damage from these superoxide radicals is mitochondrial DNA (mtDNA). As the mtDNA damage accumulates over time, mitochondria are eventually shutting down, causing cells to die, and organisms to age [131]. Such accumulating damage is believed to be crucial in the process of aging process [132, 133]. Disappointing Results from Epidemiological Studies of Anti-oxidants While a considerable body of evidence from basic science and animal studies supports the profound role of oxidative stress in pathogenesis of chronic diseases, outcomes of large, prospective, randomized clinical trials on the association between anti-oxidant supplements and these diseases have remained largely inconclusive. The following sections summarize the largest, most highly publicized trials of antioxidant supplements conducted to date The ATBC (Alpha-Tocopherol Beta-Carotene) [134] trial was one of the first large, randomized clinical trials showing that supplemental α-tocopherol and β-carotene have no preventive effect on the risk of cancer or cardiovascular diseases. The ATBC trial was conducted among 29,133 male smokers in Finland, and found no reduction in CHD morbidity and mortality with vitamin E (50 mg daily) and/or β-carotene (20 mg daily) supplementation. Furthermore, there was a significant 18% increase in the incidence of lung cancer among those with β-carotene supplements. Importantly, the β- carotene dosage of 20 mg/day was substantially higher than that of typical Finnish diet [32]. Unexpected increases in risk of both lung cancer and cardiovascular disease mortality were also observed in the CARET (Beta-Carotene and Retinol Efficacy Trial), a multicenter, randomized, double-blinded, placebo-controlled trial conducted in the United States [135]. In the CARET study, a total of 18,314 current and former smokers, and workers exposed to asbestos were randomized to receive 30 mg of β-carotene and 25,000 IU of...

Related to Oxidative stress

  • Influenza Vaccination The parties agree that influenza vaccinations may be beneficial for patients and employees. Upon a recommendation pertaining to a facility or a specifically designated area(s) thereof from the Medical Officer of Health or in compliance with applicable provincial legislation, the following rules will apply:

  • Treatment of Client Property Unless otherwise provided, the Contractor shall ensure that any adult client receiving services from the Contractor has unrestricted access to the client’s personal property. The Contractor shall not interfere with any adult client’s ownership, possession, or use of the client’s property. The Contractor shall provide clients under age eighteen (18) with reasonable access to their personal property that is appropriate to the client’s age, development, and needs. Upon termination of services to a client, the Contractor shall immediately release to the client and/or the client’s guardian or custodian all of the client’s personal property.

  • Influenza Vaccine Upon recommendation of the Medical Officer of Health, all employees shall be required, on an annual basis to be vaccinated and or to take antiviral medication for influenza. If the costs of such medication are not covered by some other sources, the Employer will pay the cost for such medication. If the employee fails to take the required medication, she may be placed on an unpaid leave of absence during any influenza outbreak in the home until such time as the employee has been cleared by the public health or the Employer to return to the work environment. The only exception to this would be employees for whom taking the medication will result in the employee being physically ill to the extent that she cannot attend work. Upon written direction from the employee’s physician of such medical condition in consultation with the Employer’s physician, (if requested), the employee will be permitted to access their sick bank, if any, during any outbreak period. If there is a dispute between the physicians, the employee will be placed on unpaid leave. If the employee gets sick as a reaction to the drug and applies for WSIB the Employer will not oppose the application. If an employee is pregnant and her physician believes the pregnancy could be in jeopardy as a result of the influenza inoculation and/or the antiviral medication she shall be eligible for sick leave in circumstances where she is not allowed to attend at work as a result of an outbreak. This clause shall be interpreted in a manner consistent with the Ontario Human Rights Code.

  • Hepatitis B Vaccine Where the Hospital identifies high risk areas where employees are exposed to Hepatitis B, the Hospital will provide, at no cost to the employees, a Hepatitis B vaccine.

  • Treatment Program Testing The Employer may request or require an employee to undergo drug and alcohol testing if the employee has been referred by the employer for chemical dependency treatment or evaluation or is participating in a chemical dependency treatment program under an employee benefit plan, in which case the employee may be requested or required to undergo drug or alcohol testing without prior notice during the evaluation or treatment period and for a period of up to two years following completion of any prescribed chemical dependency treatment program.

  • Biological Samples If so specified in the Protocol, Institution and Principal Investigator may collect and provide to Sponsor or its designee Biological Samples (“Biological Samples”). 12.2.

  • Infectious Disease Where an employee produces documentary evidence that:

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • GARBAGE DISPOSAL, RECYCLING, AND BIODEGRADABLE MATERIALS A. Concessionaire shall be responsible for maintaining the cleanliness of the Concession Premises. Concessionaire shall ensure placement of all garbage and trash generated by the Concession Operation in designated containers and that said containers are emptied daily, or as more frequently required by Department, at a location within the Area designated by Department. Disposal costs from this latter location shall be borne by Department. Concessionaire shall provide such additional trash containers as may be required to keep the immediate Concession Premises clean at all times. The type of trash containers provided by Concessionaire shall be approved by Department prior to use.

  • Infectious Diseases The Employer and the Union desire to arrest the spread of infectious diseases in the nursing home. To achieve this objective, the Joint Health and Safety Committee may review and offer input into infection control programs and protocols including surveillance, outbreak control, isolation, precautions, worker education and training, and personal protective equipment. The Employer will provide training and ongoing education in communicable disease recognition, use of personal protective equipment, decontamination of equipment, and disposal of hazardous waste.

Time is Money Join Law Insider Premium to draft better contracts faster.